Plasma metanephrines in the diagnosis of pheochromocytoma

Annals of Internal Medicine

Volumn 123, Issue 2, 1995, Pages 101-109

  Lenders, Jacques W M ^a   Keiser, Harry R ^c   Goldstein, David S ^b   Willemsen, Jacques J ^a   Friberg, Peter ^d   Jacobs, Marie Cécile ^a   Kloppenborg, Peter W C ^a   Thien, Theo ^a   Eisenhofer, Graeme ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; METADRENALIN; NORADRENALIN; NORMETADRENALIN;

ADOLESCENT; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE METABOLISM; CATECHOLAMINE URINE LEVEL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL;

EID: 0029166813     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-123-2-199507150-00004     Document Type: Article

References (34)

1. Manger WM, Gifford RW Jr. Pheochromocytoma. New York: Springer-Verlag; 1977.
2. Bravo EL, Tarazi RC, Gifford RW, Stewart BH. Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. N Engl J Med. 1979;301:682-6.
3. Pheochromocytoma: current concepts of diagnosis and treatment. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med. 1966;65:1302-26.
4. Bravo EL, Gifford RW Jr. Current concepts. Pheochromocytoma: diagnosis, localization and management. N Engl J Med. 1984;311:1298-303.
5. Lenders JW, Willemsen JJ, Beissel T, Kloppenborg PW, Thien T, Benraad TJ. Value of the plasma norepinephrine/3,4-dihydroxyphenylglycol ratio for the diagnosis of pheochromocytoma. Am J Med. 1992;92:147-52.
6. Duncan MW, Compton P, Lazarus L, Smythe GA. Measurement of norepinephrine and 3,4- dihydroxyphenylglycol in urine and plasma for the diagnosis of pheochromocytoma. N Engl J Med. 1988;319:136-42.
7. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol. 1978;41:233-43.
8. Cryer PE. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med. 1980;303:436-44.
9. Bravo EL, Tarazi RC, Fouad FM, Vidl DG, Gifford RW Jr. Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma. N Engl J Med. 1981;305:623-6.
10. Grossman E, Goldstein DS, Hoffman A, Keiser HR. Glucagon and clonidine testing in the diagnosis of pheochromocytoma. Hypertension. 1991;17:733-41.
11. Stein PP, Black HR. A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience. Medicine (Baltimore). 1991;70:46-66.
12. Graefe KH, Henseling M. Neuronal and extraneuronal uptake and metabolism of catecholamines. Gen Pharmacol. 1983;14:27-33.
13. Goldstein DS, Eisenhofer G, Stull R, Folio CJ, Keiser HR, Kopin U. Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J Clin Invest. 1988;81:213-20.
14. Eisenhofer G, Pecorella W, Pacak K. Hooper D, Kopin U, Goldstein DS. The neuronal and extraneuronal origins of plasma 3-methoxy-4-hydroxyphenylglycol in rats. J Auton Nerv Sys. 1994;50:93-107.
15. Brown MJ. Simultaneous assay of noradrenaline and its deaminated metabolite, dihydroxyphenylglycol, in plasma: a simplified approach to the exclusion of pheochromocytoma in patients with borderline elevation of plasma noradrenaline concentration. Eur J Clin Invest. 1984; 14:67-72.
16. Eisenhofer G, Åneman A, Hooper D, Holmes C, Goldstein DS, Friberg P. Production and metabolism of dopamine and norepinephrine in mesenteric organs and liver of swine. Am J Physiol. 1995;268:G641-9.
17. Peaston RT, Lai LC. Biochemical detection of phaeochromocytoma: should we still be measuring urinary HMMA? J Clin Pathol. 1993;46: 734-7.
18. Eisenhofer G, Friberg P, Pacak K, Goldstein DS, Murphy DL, Tsigos C, et al. Plasma metanephrines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism? Clin Sci. 1995;88:533-42.
19. Rosano TG, Swift TA, Hayes LW. Advances in catecholamine and metabolite measurements for diagnosis of pheochromocytoma. Clin Chem. 1991;37:1854-67.
20. Lenders JW, Eisenhofer G, Armando I, Keiser HR, Goldstein DS, Kopin U. Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin Chem. 1993;39:97-103.
21. Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL, et al. Simultaneous liquid Chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihyroxyphenyl-alanine in plasma and their responses to inhibition of monoamine oxidase. Clin Chem. 1986;32:2030-3.
22. van der Hoorn FA, Boomsma F, Man in't Veld AJ, Schalekamp MA. Determination of catecholamines in human plasma by high-performance liquid chromatography: comparison between a new method with fluorescence detection and an established method with electrochemical detection. J Chromatogr. 1989;487:17-28.
23. Pisano JJ. A simple analysis of normetanephrine and metanephrine in urine. Clin Chim Acta. 1960;5:406-14.
24. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. Boston: Little, Brown; 1991.
25. Beck JR, Shultz EK. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med. 1986;110:13-20.
26. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839-43.
27. Marini M, Fathi M, Valloton M. Dosage des métanéphrines sériques pour le diagnostic du phéochromocytome. Ann d'Endocrinol (Paris). 1993;54:337-42.
28. Fogarty J, Engel CC Jr, Russo J, Simon G, Katon W. Hypertension and pheochromocytoma testing. Arch Fam Med. 1994;3:55-60.
29. Eisenhofer G, Rundquist B, Åneman A, Friberg P, Dakak N, Kopin LT, et al. Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. J Clin Endocrinol Metab. 1995; [In press].
30. Sjoerdsma A, King WM, Leeper LC, Undenfriend S. Demonstration of the 3-methoxy analog of norepinephrine in man. Science. 1957;127: 876.
31. Kopin U, Axelrod J. Presence of 3-methoxy-4-hydroxyphenylglycol and metanephrine in phaeochromocytoma tissue. Nature. 1960;185:788.
32. DeQuattro V, Sullivan P, Foti A, Bornheimer J, Schoentgen S, Versales G, et al. Central and peripheral normetadrenaline in evaluation of neurogenic aspects of hypertension: aid to diagnosis of pheochromocytoma. Clin Sci. 1980;59(Suppl 6):275s-7s.
33. Crout J, Sjoerdsma A. Turnover and metabolism of catecholamines in patients with pheochromocytoma. J Clin Invest. 1964;43:94-102.
34. Mornex R, Peyrin L, Pagliari R, Cottet-Emard JM. Measurement of plasma methoxyamines for the diagnosis of pheochromocytoma. Horm Res. 1991;36:220-6.